Penile cancer is a rare malignancy, but one with uniquely profound consequences for sexual health, body image, and intimate relationships. While advances in surgical management have improved ...

A systematic review and meta-analysis compared the perioperative and oncologic outcomes of open versus minimally invasive inguinal lymphadenectomy during penile cancer surgery.

Increasing body mass index (BMI) is associated with a greater likelihood of invasive penile cancer and more advanced penile cancer at presentation, according to study findings published online in ...

Patients with locally advanced penile squamous cell carcinoma who responded to neoadjuvant chemotherapy followed by consolidative lymphadenectomy experienced improved long-term survival outcomes.

Although penile cancer represents less than 1% of male malignancies, it carries substantial physical and psychological burden, with a five-year survival rate near 50%. Around half of Penile squamous ...

In a phase 2 trial of patients with advanced penile cancer mostly refractory to platinum-based chemotherapy, avelumab treatment produced objective response in a few, but did not prolong survival ...

Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis, especially in advanced stages. Because of its rarity, few studies focus on better understanding ...

Keytruda plus platinum-based chemotherapy appeared to be safe and effective in treating penile squamous cell carcinoma. Keytruda (pembrolizumab) plus platinum-based chemotherapy was both safe and ...

A father from Liverpool, Patrick Howard, 65, has defied a "bleak"12-month prognosis after undergoing "radical" treatment for terminal penile cancer. The retiree, who lives with his 59-year-old wife ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.